Richard Lowenthal

Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO.

Part of Viatris, Inc., Somerset Pharmaceuticals, Inc. is a company that manufactures pharmaceutical products. The company is based in Tampa, FL.

Vecta Ltd. develops products for the gastrointestinal diseases. Its product VECAM-111 meets a well-known unmet need to address symptoms of gastroesophageal reflux disease (GERD) that are not commonly addressed by existing therapeutic options. The company develops enhanced novel drug formulation for symptomatic GERD. Vecta was founded by Yehuda Chowers and Dan J. Gelvan in 2001 and is headquartered in Ramat Gan, Israel.

Momotaro-Gene Inc. engages in the development of molecular targeting drugs for cancer treatment. It also acting as a bridge between promising technology seeds in life science and real drug market in order to effectively bringing the research outcome to the citizens globally. The company was founded on August 17, 2007 and is headquartered in Okayama, Japan.

ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA.